Mike Gatto

Mike Gatto

Ask VT AI
View News Summary
  • Moderna's mRNA-based flu vaccine outperforms standard flu shot in global Phase 3 trial, paving the way for COVID-19 combination vaccines.
  • UBS launches new $2 billion share buyback despite Swiss capital rule threat, reaffirming commitment to capital returns.
  • Yankees place two players on IL, but one expected back soon as team depth is tested.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Moderna's mRNA-based flu vaccine outperforms standard flu shot in global Phase 3 trial, paving the way for COVID-19 combination vaccines.
  • UBS launches new $2 billion share buyback despite Swiss capital rule threat, reaffirming commitment to capital returns.
  • Yankees place two players on IL, but one expected back soon as team depth is tested.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Mike Gatto